POINT: Eli Lilly: has extended its tender offer for Point Biopharma

(marketscreener.com) Eli Lilly has announced the extension of the expiration of its tender offer to acquire all of the issued and outstanding shares of Point Biopharma Global common stock, for a purchase price of $12.50 per share in cash.The tender offer, which was due to expire on November 16, 2023 at 5:00 p.m., has been extended to December 1, 2023 at 5:00 p.m.,...https://www.marketscreener.com/quote/stock/ELI-LILLY-AND-COMPANY-13401/news/Eli-Lilly-has-extended-its-tender-offer-for-Point-Biopharma-45399312/?utm_medium=RSS&utm_content=20231120